Biotech Values

[genisi]

Simeprevir's actual label says the drug is "indicated as a component of a combination antiviral treatment regimen." That is written broadly enough to where it's not clear that simeprevir+sofosbuvir use would necessarily be deemed off-label.

It's not clear but since simeprevir+sofosbuvir combo is yet to be approved, it sounds as off label for the time being and on label in combo with peginterferon-alfa and ribavirin.